Literature DB >> 8206134

Toxoplasma gondii: activity of the polyether ionophorous antibiotic nigericin on tachyzoites in cell culture.

S Couzinet1, J F Dubremetz, L David, G Prensier.   

Abstract

Polyether ionophorous antibiotics are widely used prophylactically to prevent coccidiosis in livestock production. The study of the effects of the nigericin on tachyzoites of Toxoplasma gondii clearly demonstrated that very low concentrations of this ionophore (0.05 microgram/ml) were sufficient to inhibit strongly the penetration and totally inhibit the intracellular development of parasites. Both nigericin and epinigericin showed a similar activity against tachyzoite development. However, the activity of abierixicin was 50-fold lower. Such antibiotic concentrations did not seem to affect host cells. Immunofluorescence and electron microscopy showed important changes in the cytology of the antibiotic-treated parasites: they were vacuolated or swollen and were sometimes found burst open, having lost their original shape. The magnitude and the frequency of alterations rose as concentrations in ionophore increased.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206134     DOI: 10.1006/expr.1994.1037

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  3 in total

1.  Phagocytic uptake of Encephalitozoon cuniculi by nonprofessional phagocytes.

Authors:  S Couzinet; E Cejas; J Schittny; P Deplazes; R Weber; S Zimmerli
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites.

Authors:  Dion A Kevin Ii; Damaris Af Meujo; Mark T Hamann
Journal:  Expert Opin Drug Discov       Date:  2009-02       Impact factor: 6.098

3.  Toxoplasma gondii: induction of egress by the potassium ionophore nigericin.

Authors:  Ingrid A Fruth; Gustavo Arrizabalaga
Journal:  Int J Parasitol       Date:  2007-06-09       Impact factor: 3.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.